✦ LIBER ✦

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

✍ Scribed by Toshirou Nishida; Kuniaki Shirao; Akira Sawaki; Masato Koseki; Takeshi Okamura; Atsushi Ohtsu; Toshiro Sugiyama; Kunihisa Miyakawa; Seiichi Hirota

Publisher: Springer
Year: 2008
Tongue: English
Weight: 258 KB
Volume: 13
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-007-0746-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of motesanib in Japanese

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

✍ Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Mas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 302 KB

A two-arm phase II study of temozolomide

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas

✍ Jonathan C. Trent; Jennifer Beach; Michael A. Burgess; Nicholas Papadopolous; Le 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a two‐arm Phase II study of temozolomide to determine its efficacy and toxicity in patients with soft tissue sarcomas (STSs) who had received, had refused, or were not eligible for standard chemotherapy with doxorubicin and ifosfamide (Arm 1) and in

Imatinib plus low-dose doxorubicin in pa

Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib : A phase I-II study by the Spanish group for research on sarcomas

✍ Joan Maurel; Ana Sofia Martins; Andrés Poveda; José Antonio López-Guerrero; Rica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 3 views

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

A two-part Phase II study of cediranib i

A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

✍ Claire L. Mitchell; J. P. B. O’Connor; C. Roberts; Y. Watson; A. Jackson; S. Che 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 631 KB